Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
Search Results
5
results
Results by year
Page 1
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.
Neurology. 2021 Oct 19;97(16):e1546-e1559. doi: 10.1212/WNL.0000000000012700. Epub 2021 Sep 2.
Neurology. 2021.
PMID: 34475123
Free PMC article.
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Bar-Or A, Calkwood JC, Chognot C, Evershed J, Fox EJ, Herman A, Manfrini M, McNamara J, Robertson DS, Stokmaier D, Wendt JK, Winthrop KL, Traboulsee A.
Bar-Or A, et al. Among authors: chognot c.
Neurology. 2020 Oct 6;95(14):e1999-e2008. doi: 10.1212/WNL.0000000000010380. Epub 2020 Jul 29.
Neurology. 2020.
PMID: 32727835
Free PMC article.
Clinical Trial.
Item in Clipboard
Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Knapp R, Hardtstock F, Krieger J, Wilke T, Maywald U, Chognot C, Muros-Le Rouzic E, Craveiro L.
Knapp R, et al. Among authors: chognot c.
Mult Scler Relat Disord. 2022 Dec;68:104245. doi: 10.1016/j.msard.2022.104245. Epub 2022 Oct 17.
Mult Scler Relat Disord. 2022.
PMID: 36306609
Free article.
Item in Clipboard
Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.
Henry RR, Lincoff AM, Mudaliar S, Rabbia M, Chognot C, Herz M.
Henry RR, et al. Among authors: chognot c.
Lancet. 2009 Jul 11;374(9684):126-35. doi: 10.1016/S0140-6736(09)60870-9. Epub 2009 Jun 8.
Lancet. 2009.
PMID: 19515415
Clinical Trial.
Item in Clipboard
Comparing the risk of serious infections in patients with and without MS: A German claims data analysis.
Knapp R, Hardtstock F, Wilke T, Maywald U, Chognot C, Craveiro L, Rouzic EM.
Knapp R, et al. Among authors: chognot c.
Mult Scler Relat Disord. 2023 Feb 21;72:104583. doi: 10.1016/j.msard.2023.104583. Online ahead of print.
Mult Scler Relat Disord. 2023.
PMID: 36905817
Free article.
Item in Clipboard
Cite
Cite